Navigation Links
Photos: Sentara Joins 4 U.S. Hospitals in International 'TARGIT' Breast Cancer Trial

- TARGIT Procedure May Eliminate 6 Weeks of Radiation Therapy - Event: Watch Single-Dose Radiation Treatment over the Internet Wednesday, October 22, 2008, 3 - 4 p.m. by visiting

HAMPTON, Va., Oct. 6 /PRNewswire/ - Questions raced through Vela Cross' mind when she was diagnosed with breast cancer in May. Would she have the tumor removed or her entire breast? How about radiation or chemotherapy?

To view the Multimedia News Release, go to:

With doctors at Sentara CarePlex Hospital involved in the international TARGIT Trial, Cross became the first East Coast patient to receive this revolutionary treatment option.

Sentara CarePlex Hospital in Hampton, Virginia is among five U.S. centers and 22 worldwide enrolling patients in this study open to early-stage breast cancer patients. The study evaluates the effectiveness of an investigational single-dose internal radiation treatment compared with conventional external radiation.

The TARGIT Trial, which stands for TARGeted Intraoperative-radiation Therapy, could eliminate the need for six weeks of daily radiation.

"Regular radiation would have really interrupted my life," says Cross.

"Some women consider a mastectomy rather than facing weeks of conventional radiation," says surgical oncologist Dr. Richard Hoefer. "We hope our participation offers women another option," he continues.

Half of trial participants get the investigational one-time dose of radiation through an applicator placed in the tumor cavity. The radiation is targeted to breast cells with the highest risk of cancer recurrence-those that directly surrounded the tumor. Other trial participants receive 6-8 weeks of external radiation.

Equipment involved in this study was cleared by the U.S. FDA as safe and effective; trials at Sentara are subject to rigorous approvals.

"This study could significantly change the way we care for early-stage breast cancer patients," says Dr. Michael Miller, medical director of CarePlex Hospital's radiation oncology department.

TARGIT is a randomized phase III study, enrolling post-menopausal women at least 45 years old with single-site invasive breast cancer measuring less than 3 centimeters. For a patient to receive the single-dose radiation, they must be a candidate for the TARGIT Trial. Other considerations include type of cancer, tumor size, and lymph node involvement. To learn more, call 757-594- 1939 or visit

SOURCE Sentara CarePlex Hospital
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. General Wesley Clark Joins Immtech as Consulting Strategic Advisor
2. Actress and New Mom Keri Russell Joins PKIDs to launch Silence the Sounds of Pertussis Campaign
3. Video: Actress and New Mom Keri Russell Joins PKIDs to Launch Silence the Sounds of Pertussis Campaign
4. Actress and Mother Jennifer Garner Joins American Lung Association to Encourage Americans to Get an Influenza Vaccination
5. MedicAlert Foundation Joins The Alzheimers Association to Offer MedicAlert(R) + Alzheimers Association Safe Return(R) - Live 24-Hour Emergency Response for Wandering and Medical Emergencies
6. Olympic Gold Medalist Kristi Yamaguchi Joins American Lung Association of Michigan to Address Seriously Low Vaccination Rates; Urge Metro-Detroiters to Get Immunized This Season
7. William R. Ringo Joins Hyperion Therapeutics, Inc. Board of Directors as Chairman
8. Dr. Rajeev Venkayya Joins Gates Foundation as Director of Global Health Delivery
9. Dr. Harriet Robinson Joins GeoVax Team as V.P. of R & D to Accelerate AIDS Vaccine Trials Program
10. Dr. Peter Nash, Ph.D. Joins Mach One Corporation as Chief Scientist
11. Judith Quinlan Joins Cytel as Vice President, Adaptive Trials
Post Your Comments:
(Date:10/10/2017)... 10, 2017   West Pharmaceutical Services, Inc. ... injectable drug administration, today shared the results of a ... improving the intradermal administration of polio vaccines. The study ... in May 2017 by Dr. Ondrej Mach , ... Health Organization (WHO), and recently published in the journal ...
(Date:10/5/2017)... 5, 2017  In response to the nationwide ... Maxillofacial Surgeons (AAOMS) released prescribing recommendations that urge ... used as a first-line therapy to manage a ... Recognizing the value and importance ... "Opioid Prescribing: Acute and Postoperative Pain Management" stresses ...
(Date:10/4/2017)... 2017  According to the Centers for Disease Control and Prevention (CDC), ... PhysicianOne Urgent Care is helping communities across Massachusetts , ... by offering no-cost* flu shots through the end of the month. ... insurance regulations. ... get a flu shot is by the end of October, according to ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... Lori R. Somekh, founder of the ... a national organization of elder law and special needs planning attorneys. “Membership in ElderCounsel ... also provides a forum to network with elder law attorneys nationwide,” said Somekh. ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network ... advocate for action towards gender equality at their inaugural Summit in New York City ... and reached a social audience of over 3 million. To watch the Mobilize Women ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader in agile ... a contract by the Center for Medicare and Medicaid Services (CMS). The Enterprise ... use of Agile methodologies in a consistent and high value manner across CMS ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San ... using cutting-edge Oventus O2Vent technology. As many as 18 million Americans are ... cessation in breathing. Oral appliances can offer significant relief to about 75 percent ...
(Date:10/12/2017)... Bethesda, MD (PRWEB) , ... October 12, 2017 , ... ... Award of Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s ... 4 – 8. , In honor of Morris F. Collen, a pioneer in the ...
Breaking Medicine News(10 mins):